Picard Medical, Inc. PMI
Picard Medical, Inc. (NYSE: PMI) is a cardio-renal-metabolic medical device company. Its next catalyst on record is Unicorn driver: Complete regulatory testing (H2 2026).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: Unicorn driver — Complete regulatory testing (H2 2026). 4 catalysts on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| SynCardia TAH (PMA-approved BTT) | Bridge to transplant | — | NA_NON_THERAPEUTIC |
| Freedom+ portable driver (PMA supplements under FDA review) | — | — | NA_NON_THERAPEUTIC |
| Unicorn driver system | — | — | NA_NON_THERAPEUTIC |
| Emperor TAH (fully implantable) | End-stage heart failure | — | NA_NON_THERAPEUTIC |
Recent results and decisions
- Oct 22, 2026n/a Picard Medical issued 200,000 shares of common stock to placement agent warrant holders in exchange for surrender of warrants originally exercisable for 8,187,766 pre-split shares.
On October 22, 2026, after satisfaction of the applicable conditions, the Company issued 200,000 Exchange Shares to the Warrant Holders solely in exchange for the Warrants, without cash or other consideration to the Company.
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other cardio-renal-metabolic companies
- DexCom, Inc. DXCM
- Penumbra Inc PEN
- Insulet Corp PODD
- MiniMed Group, Inc. MMED
- Heartflow, Inc. HTFL
- iRhythm Holdings, Inc. IRTC
- Pulse Biosciences, Inc. PLSE
- AtriCure, Inc. ATRC
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.